CO4290364A1 - Agentes antitromboticos de tripeptidos - Google Patents

Agentes antitromboticos de tripeptidos

Info

Publication number
CO4290364A1
CO4290364A1 CO94040971A CO94040971A CO4290364A1 CO 4290364 A1 CO4290364 A1 CO 4290364A1 CO 94040971 A CO94040971 A CO 94040971A CO 94040971 A CO94040971 A CO 94040971A CO 4290364 A1 CO4290364 A1 CO 4290364A1
Authority
CO
Colombia
Prior art keywords
tripeptides
antithrombotic agents
compound
formula
amino
Prior art date
Application number
CO94040971A
Other languages
English (en)
Inventor
Paul David Gesellchen
Robert Theodore Shuman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO4290364A1 publication Critical patent/CO4290364A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

REIVINDICACION NUMERO UN COMPUESTO DE LA FORMULA 1 FIGURA 1 DONDE A ES FIGURA 2 Y USS SALES Y SOLVATOS ACEPTABLES FARMACEUTICAMEN- TE". REIVINDICACION NUMERO UN PROCEDIMIENTO PARA PREPARAR UN COMPUESTO DE LA FORMULA FIGURA 3 DONDE A ES FIGURA 4 Y SUS SALES ACEPTABLES FARMACEUTICAMENTE, QUE COM- PRENDE ELIMINAR GRUPOS DE BLOQUEO DE AMINO DE UN COMPUESTO DE LA FORMULA FIGURA 5 DONDE A ES FIGURA 6 Y P ES UN GRUPO PROTECTOR DE AMINO".
CO94040971A 1993-09-14 1994-09-12 Agentes antitromboticos de tripeptidos CO4290364A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (1)

Publication Number Publication Date
CO4290364A1 true CO4290364A1 (es) 1996-04-17

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
CO94040971A CO4290364A1 (es) 1993-09-14 1994-09-12 Agentes antitromboticos de tripeptidos

Country Status (31)

Country Link
US (1) US5430023A (es)
EP (1) EP0643073B1 (es)
JP (1) JPH07149791A (es)
KR (1) KR100312388B1 (es)
CN (1) CN1055698C (es)
AT (1) ATE160574T1 (es)
AU (1) AU674773B2 (es)
BR (1) BR9403542A (es)
CA (1) CA2131982C (es)
CO (1) CO4290364A1 (es)
CY (1) CY2072B1 (es)
CZ (1) CZ286139B6 (es)
DE (1) DE69407006T2 (es)
DK (1) DK0643073T3 (es)
ES (1) ES2110186T3 (es)
FI (1) FI944231A (es)
GR (1) GR3026115T3 (es)
HU (1) HU220620B1 (es)
IL (1) IL110933A (es)
MY (1) MY112879A (es)
NO (1) NO310240B1 (es)
NZ (1) NZ264438A (es)
PE (1) PE43695A1 (es)
PH (1) PH31655A (es)
PL (1) PL176448B1 (es)
RU (1) RU2105010C1 (es)
SI (1) SI0643073T1 (es)
TW (1) TW275622B (es)
UA (1) UA32556C2 (es)
YU (1) YU54194A (es)
ZA (1) ZA947015B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69314478T2 (de) * 1992-03-04 1999-02-11 Gyogyszerkutato Intezet Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
AU1884395A (en) * 1994-03-04 1995-09-18 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
CA2289625A1 (en) 1997-05-15 1998-11-19 Charles Van Jackson Antithrombotic compound
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
CN1326496C (zh) * 2002-02-11 2007-07-18 黄金－T技术股份有限公司 预防血栓形成的装置
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Also Published As

Publication number Publication date
CZ286139B6 (cs) 2000-01-12
CA2131982A1 (en) 1995-03-15
ZA947015B (en) 1996-03-12
ATE160574T1 (de) 1997-12-15
GR3026115T3 (en) 1998-05-29
KR950008534A (ko) 1995-04-19
BR9403542A (pt) 1995-06-20
HUT67849A (en) 1995-05-29
EP0643073B1 (en) 1997-11-26
YU54194A (sh) 1997-01-08
US5430023A (en) 1995-07-04
MY112879A (en) 2001-10-31
PE43695A1 (es) 1995-12-09
NO943402D0 (no) 1994-09-13
NO310240B1 (no) 2001-06-11
PH31655A (en) 1999-01-12
RU94034734A (ru) 1996-07-20
SI0643073T1 (en) 1998-08-31
NO943402L (no) 1995-03-15
HU220620B1 (hu) 2002-03-28
TW275622B (es) 1996-05-11
AU674773B2 (en) 1997-01-09
AU7294894A (en) 1995-03-30
RU2105010C1 (ru) 1998-02-20
HU9402626D0 (en) 1994-11-28
IL110933A (en) 1998-12-27
DE69407006D1 (de) 1998-01-08
ES2110186T3 (es) 1998-02-01
FI944231A0 (fi) 1994-09-13
PL305009A1 (en) 1995-03-20
DK0643073T3 (da) 1997-12-29
NZ264438A (en) 1996-06-25
CN1106819A (zh) 1995-08-16
IL110933A0 (en) 1994-11-28
DE69407006T2 (de) 1998-04-16
FI944231A (fi) 1995-03-15
UA32556C2 (uk) 2001-02-15
CN1055698C (zh) 2000-08-23
EP0643073A1 (en) 1995-03-15
JPH07149791A (ja) 1995-06-13
KR100312388B1 (ko) 2001-12-28
CA2131982C (en) 2003-07-29
CZ222094A3 (en) 1995-03-15
PL176448B1 (pl) 1999-05-31
CY2072B1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
CO4290364A1 (es) Agentes antitromboticos de tripeptidos
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
TR199700727T1 (xx) Farnesil transferaz�n�n yeni inhibit�rleri.
FI972935A0 (fi) Kalpaiinin ja/tai katepsiini B:n substituoituja oksatsolidiiniestäjiä
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
DE69530081T2 (de) Gastrin- und cck-antagonisten
IL104489A0 (en) Carbamates and crop protection agents containing them
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
FI970858A0 (fi) Tirilasadin parenteraalinen apuliuotinformulaatio
CO4410181A1 (es) Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol
MX203891B (es) Compuestos funcionales de 1, 3-dicetoamida etilenicamente insaturados, polimeros de los mismos y formulaciones de latex que contienen los mismos
ITMI932539A0 (it) Procedimento per la terminazione di polimerizzazione in emulsione che non genera nitrosammine
TR199600471A2 (tr) COCCIDIOSIS'e karsi uygulanan yumurta ici asilama.
ITMI932569A0 (it) Procedimento e dispositivo per l'equilibratura dinamica di un rotore.
MX9702035A (es) Inhibidores de 5-alfa reductasa.
ATE229800T1 (de) Guanidino proteiase inhibitoren
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
DK0914078T3 (da) Anvendelse af L-lysin til behandling af hårtab
NO980296L (no) Forbedrede terapeutiske midler
EP0342369A3 (de) Schutzmittel gegen Karies
ES2164096T3 (es) Antagonistas de lhrh que comprenden restos de aminoacilo modificados en posicion 5 y 6.
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
DE69530062D1 (de) "Capsaicinoid" enthaltendes Tränengas
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу